A Clinical study on cervical spondylosis using thengaai thuruval ottradam (external therapy)

Phase 2

Completed

• Conditions: Other spondylosis,

• Registration Number: CTRI/2021/02/031542
• Lead Sponsor: Government Siddha medical college and hospital

Brief Summary

The study is A Clinical study to evaluate the therapeutic efficacy of THENGAAI THURUVAL OTTRADAM in the management of cegana vatham (cervical spondylosis). The trial will be given externally as a ottradam therapy for 48 days in 40 patients. The trial period of 12 months will be carrying out in government Siddha medical college and hospital, Palayamkottai Tirunelveli TamilNadu. Primary outcome is improvement in lab parameters and relief of clinical symptoms. The secondary outcome is reduction in restriction of movements and evaluate the effect of ottradam. In case of any adverse event (AE) is noticed and it will be referred to pharmacovigilance department of SCRI. Further management of patient will be given in OPD facility.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-03
• Study Completion: 2022-04-28
• Last Update Posted: 2022-05-30

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Neck pain Radiating pain to upper limbs With or without numbness in the upper limbs Giddiness and neck stiffness Patients who are willing to give blood samples for laboratory investigation Patients who are willing to take X-ray before and after treatment Willing for admission in IPD for 48 days or willing to attend OPD regularly Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent.

Exclusion Criteria

• Cardiac disease Tuberculosis in spine Spina bifida Use of narcotic drugs Pregnant women and lactating mother Trauma, Fracture, Ligament injury Patient with any other serious illness.
• Benign and malignant neoplasm Congenital spinal anomalies Dermatological issues.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in lab parameters and relief of clinical symptoms	48 days

Secondary Outcome Measures

Name	Time	Method
Reduction inrestriction of movements	To evaluate effect of ottradam

Trial Locations

Locations (1)

Government Siddha medical college and hospital; 🇮🇳 Tirunelveli, TAMIL NADU, India

Government Siddha medical college and hospital

🇮🇳Tirunelveli, TAMIL NADU, India

Dr M F Muhammad Hafeez

Principal investigator

9443882877

hafeezmf75@gmail.com